Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use

IF 3.7 2区医学 Q1 PSYCHOLOGY, CLINICAL Addictive behaviors Pub Date : 2024-05-28 DOI:10.1016/j.addbeh.2024.108076

Shivani Mathur Gaiha , Maggie Wang , Mike Baiocchi , Bonnie Halpern-Felsher

{"title":"Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use","authors":"Shivani Mathur Gaiha , Maggie Wang , Mike Baiocchi , Bonnie Halpern-Felsher","doi":"10.1016/j.addbeh.2024.108076","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Few studies examine the relationship between depression and use of specific tobacco and/or cannabis products among adolescents, young adults, and adults. We determined whether the odds of depression are greater among those who used specific tobacco and/or cannabis products and among co-users of tobacco and cannabis.</p></div><div><h3>Method</h3><p>Cross-sectional online survey of a national convenience sample of 13–40-year-olds (N = 6,038). The survey included depression screening and past 30-day use of specific tobacco and cannabis products (cigarettes; e-cigarettes, vaped cannabis, little cigars, cigarillos, cigars, hookah, chewing tobacco, smoked cannabis, edible cannabis, blunts). Analyses correspond to the total sample, and 13–17-, 18–24-, and 25–40-year-olds.</p></div><div><h3>Results</h3><p>Among 5,281 individuals who responded to the depression screener and nine product use questions, 1,803 (34.1 %) reported co-use of at least one tobacco product and one cannabis product in the past 30 days. Past 30-day co-use was associated with higher likelihood of screening positive for depression compared to past 30-day use of tobacco-only (aOR = 1.32, 1.06–1.65; 0.006) or cannabis-only (aOR = 1.94, 1.28–2.94; <0.001). Screening positive for depression was more likely among those who reported past 30-day use of e-cigarettes (aOR = 1.56; 1.35–1.80; <0.001), cigarettes (aOR = 1.24, 1.04–1.48; 0.016), chewed tobacco (aOR = 1.91, 1.51–2.42; <0.001), and blunts (aOR = 1.22, 1.00–1.48; 0.053) compared to those who did not report past 30-day use of these products. Among the 2,223 individuals who screened positive for depression, the most used two-product combination was nicotine e-cigarettes and smoked cannabis (614 individuals, 27.6 %).</p></div><div><h3>Conclusions</h3><p>Screening positive for depression was more likely among past 30-day co-users versus past 30-day users of tobacco-only or cannabis-only. Findings suggest that prevention programs for depression and substance use address tobacco and cannabis co-use.</p></div>","PeriodicalId":7155,"journal":{"name":"Addictive behaviors","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive behaviors","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306460324001254","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Few studies examine the relationship between depression and use of specific tobacco and/or cannabis products among adolescents, young adults, and adults. We determined whether the odds of depression are greater among those who used specific tobacco and/or cannabis products and among co-users of tobacco and cannabis.

Method

Cross-sectional online survey of a national convenience sample of 13–40-year-olds (N = 6,038). The survey included depression screening and past 30-day use of specific tobacco and cannabis products (cigarettes; e-cigarettes, vaped cannabis, little cigars, cigarillos, cigars, hookah, chewing tobacco, smoked cannabis, edible cannabis, blunts). Analyses correspond to the total sample, and 13–17-, 18–24-, and 25–40-year-olds.

Results

Among 5,281 individuals who responded to the depression screener and nine product use questions, 1,803 (34.1 %) reported co-use of at least one tobacco product and one cannabis product in the past 30 days. Past 30-day co-use was associated with higher likelihood of screening positive for depression compared to past 30-day use of tobacco-only (aOR = 1.32, 1.06–1.65; 0.006) or cannabis-only (aOR = 1.94, 1.28–2.94; <0.001). Screening positive for depression was more likely among those who reported past 30-day use of e-cigarettes (aOR = 1.56; 1.35–1.80; <0.001), cigarettes (aOR = 1.24, 1.04–1.48; 0.016), chewed tobacco (aOR = 1.91, 1.51–2.42; <0.001), and blunts (aOR = 1.22, 1.00–1.48; 0.053) compared to those who did not report past 30-day use of these products. Among the 2,223 individuals who screened positive for depression, the most used two-product combination was nicotine e-cigarettes and smoked cannabis (614 individuals, 27.6 %).

Conclusions

Screening positive for depression was more likely among past 30-day co-users versus past 30-day users of tobacco-only or cannabis-only. Findings suggest that prevention programs for depression and substance use address tobacco and cannabis co-use.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

报告过去 30 天吸烟和吸食大麻情况的青少年、年轻成人和成人的抑郁筛查结果

背景很少有研究探讨抑郁症与青少年、年轻人和成年人使用特定烟草和/或大麻产品之间的关系。我们确定了使用特定烟草和/或大麻产品的人群以及共同使用烟草和大麻的人群患抑郁症的几率是否更大。方法对 13-40 岁的全国便利样本（N = 6038）进行横断面在线调查。调查内容包括抑郁症筛查和过去 30 天特定烟草和大麻产品（香烟、电子烟、吸食大麻、小雪茄、雪茄烟、雪茄烟、水烟、嚼烟、吸食大麻、食用大麻、钝烟头）的使用情况。结果在回答抑郁筛查器和九个产品使用问题的 5281 人中，有 1803 人（34.1%）报告在过去 30 天内至少共同使用过一种烟草产品和一种大麻产品。与过去 30 天内只使用烟草（aOR = 1.32, 1.06-1.65; 0.006）或只使用大麻（aOR = 1.94, 1.28-2.94; <0.001）相比，过去 30 天内同时使用烟草和大麻与抑郁症筛查呈阳性的可能性更高相关。报告过去 30 天使用过电子烟（aOR = 1.56; 1.35-1.80; <0.001）、香烟（aOR = 1.24, 1.04-1.48; 0.016）、咀嚼烟草（aOR = 1.91, 1.51-2.42; <0.001）和钝烟头（aOR = 1.22, 1.00-1.48; 0.053）。在抑郁症筛查呈阳性的 2,223 人中，使用最多的两种产品组合是尼古丁电子烟和吸食大麻（614 人，27.6%）。研究结果表明，针对抑郁症和药物使用的预防计划应解决烟草和大麻共同使用的问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Addictive behaviors 医学-药物滥用

CiteScore

8.40

自引率

4.50%

发文量

283

审稿时长

46 days

期刊介绍： Addictive Behaviors is an international peer-reviewed journal publishing high quality human research on addictive behaviors and disorders since 1975. The journal accepts submissions of full-length papers and short communications on substance-related addictions such as the abuse of alcohol, drugs and nicotine, and behavioral addictions involving gambling and technology. We primarily publish behavioral and psychosocial research but our articles span the fields of psychology, sociology, psychiatry, epidemiology, social policy, medicine, pharmacology and neuroscience. While theoretical orientations are diverse, the emphasis of the journal is primarily empirical. That is, sound experimental design combined with valid, reliable assessment and evaluation procedures are a requisite for acceptance. However, innovative and empirically oriented case studies that might encourage new lines of inquiry are accepted as well. Studies that clearly contribute to current knowledge of etiology, prevention, social policy or treatment are given priority. Scholarly commentaries on topical issues, systematic reviews, and mini reviews are encouraged. We especially welcome multimedia papers that incorporate video or audio components to better display methodology or findings. Studies can also be submitted to Addictive Behaviors? companion title, the open access journal Addictive Behaviors Reports, which has a particular interest in ''non-traditional'', innovative and empirically-oriented research such as negative/null data papers, replication studies, case reports on novel treatments, and cross-cultural research.